In case of the presence of multiple Schwannomas (in a minority of cases), the risk factors for the tumor include the presence of NF2 and a positive family history of Schwannoma Schwannomas may be asymptomatic (in many cases) or symptomatic
As with all investigational agents, dosing recommendations may be refined as further Phase 3 data become available and regulatory submissions are made
While many of the drug manufacturers, as well as the various compounding pharmacies**, continue to promote and make superfluous claims on all the health benefits of GLP-1 medications, consumers need to be aware of the downsides
As peptide research accelerates, more compounds are entering clinical trials, expanding options for targeted, preventive, and regenerative therapies
That magnitude matters because it positions berobenatide as more than weight loss with modest glycemic benefits. It reads like a serious diabetes drug, not just an anti-obesity medication with metabolic side effects
Injecting into muscle changes the absorption rate and can cause more pain and bruising
